Sales of codeine-containing products such as Nurofen Plus and Solpadeine fell by almost half during August, after new guidelines for pharmacists governing their use came into effect at the beginning of the month.
Latest industry figures supplied to GlaxoSmithKline Ireland, manufacturer of a range of over-the-counter medicines including Solpadeine, show the overall number of packets of such products sold through pharmacies fell by 45% last month when compared to August 2009.
Under the new Pharmaceutical Society of Ireland guidelines on the sale and display of the products – which came into effect on 1 August – pharmacists have to ensure customers know how to use such medicines properly.
Source: John Downes, The Sunday Tribune, 03/10/2010